Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU A Rajan, CA Carter, RJ Kelly, M Gutierrez, S Kummar, E Szabo, Clinical cancer research 18 (8), 2344-2351. Kummars remarkable accomplishments, combined with her ability to connect with people and her clear vision for how to grow the hematology-oncology division, made her our top candidate. Sanjay Malhotra, Ph.D. Shivaani Kummar, M.D., FACP Read more to learn about Shivaani Kummar, MBBS's background, education, and other specialties. Dr. Jody Kujovich, MD - Portland, OR | Oncology - Doximity Patients and Methods. OHSU is an equal opportunity affirmative action institution. Dr. Kummar completed a residency at Emory University. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Early-phase trials are the first step in testing promising new medications and methods, and can offer patients early access to new and possibly better treatments. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. OHSU is an equal opportunity affirmative action institution. Neoadjuvant nivolumab shows long-term benefit in NSCLC OHSU is an equal opportunity affirmative action institution. Will you join us. Administrative Coordinator, Felicia Feingersch Early phase trials are conducted to test new treatments for cancer, while ensuring the highest standards of patient safety. Uncategorized . Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography I am humbled and inspired by the courage, grace and feeling of altruism that I find in each and every patient who chooses to participate in these trials. At the end of the day, we need to develop better treatment for cancer patients and the only way to build that is through collaboration within OHSU and with other academic centers, biotech and pharma companies., Team science can be a buzz word.
shivaani kummar ohsu email